Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics

Citation
F. Paradisi et al., Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics, MED CLIN NA, 85(1), 2001, pp. 1
Citations number
79
Language
INGLESE
art.tipo
Article
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
MEDICAL CLINICS OF NORTH AMERICA
ISSN journal
0025-7125 → ACNP
Volume
85
Issue
1
Year of publication
2001
Database
ISI
SICI code
0025-7125(200101)85:1<1:A(MMMA>2.0.ZU;2-E
Abstract
Staphylococcal infections are important causes of morbidity, mortality, and increased economic costs. Increasing emergence of resistance among staphyl ococcal strains makes therapy of these infections increasingly difficult. P enicillin, oxacillin (nafcillin), and glycopeptides are the drugs of choice for treatment of infections caused by penicillin-susceptible, penicillin-r esistant and methicillin-resistant staphylococci. Alternative antimicrobial s, such as cotrimoxazole, lincosamides, macrolides, tetracyclines, and fluo roquinolones, can be used in selected cases. Newly introduced or experiment al drugs could be useful for therapy of infections caused by multiresistant staphylococci.